The Human Insulin market was valued at USD 24.88 billion in 2018 and is predicted to grow at a CAGR of 8.1%, with forecasts for 2026 eclipsing USD 46.59 billion. The market is driven by the rising prevalence of diabetes and obesity worldwide which can be attributed to the unhealthy lifestyles. For instance, over 30 million Americans (9.4% of the population) are diagnosed with diabetes...